StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories forecasted Annual Intangible Amortization — Year 2 ($M) ($M)

Form 10-K / 10-Q Goodwill & Intangibles Footnote

Latest, FY2025
1,200
Period ended Dec 31, 2025
Change on a year earlier
-20.0%
1,500 in FY2024
History
13 years
Since FY2013
Sources
13
Documents cited below

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedForecasted Annual Intangible Amortization — Year 2 ($M) ($M)Year on yearSource
FY2025Dec 31, 20251,200-20.0%SEC Filing (0001628280-26-010185) ↗
FY2024Dec 31, 20241,500-11.8%SEC Filing (0001628280-25-007110) ↗
FY2023Dec 31, 20231,700-10.5%SEC Filing (0001628280-24-005348) ↗
FY2022Dec 31, 20221,900-5.0%SEC Filing (0001628280-23-004026) ↗
FY2021Dec 31, 20212,0000.0%SEC Filing (0001104659-22-025141) ↗
FY2020Dec 31, 20202,0000.0%SEC Filing (0001104659-21-025751) ↗
FY2019Dec 31, 20192,000-9.1%SEC Filing (0001104659-20-023904) ↗
FY2018Dec 31, 20182,200-4.3%SEC Filing (0001047469-19-000624) ↗
FY2017Dec 31, 20172,300+422.7%SEC Filing (0001047469-18-000856) ↗
FY2016Dec 31, 2016440-21.4%SEC Filing (0001047469-17-000744) ↗
FY2015Dec 31, 2015560-17.2%SEC Filing (0001047469-16-010246) ↗
FY2014Dec 31, 2014676+3.7%SEC Filing (0001047469-15-001377) ↗
FY2013Dec 31, 2013652–SEC Filing (0001047469-14-001176) ↗

Cite this data

StockData. (2026). Abbott Laboratories Forecasted Annual Intangible Amortization — Year 2 ($M) ($M), annual FY2013–FY2025 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/intang-amort-y2

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.